Search Results - "Dzwigalski, Kyle R"

Phase 1 study of selinexor in combination with salvage chemotherapy in Adults with relapsed or refractory Acute myeloid leukemia by Bhatnagar, Bhavana, Zhao, Qiuhong, Mims, Alice S, Vasu, Sumithira, Behbehani, Gregory K, Larkin, Karilyn, Blachly, James S, Badawi, Mohamed A, Hill, Kasey L, Dzwigalski, Kyle R, Phelps, Mitch A, Blum, William, Klisovic, Rebecca B, Ruppert, Amy S, Ranganathan, Parvathi, Walker, Alison R, Garzon, Ramiro

“…Selinexor, an oral inhibitor of the nuclear transport protein Exportin-1, shows promising single-agent activity in clinical trials of relapsed/refractory (R/R)…”
Get full text

Abstract 6118: A primary mouse model of AML as a new way to screen novel therapeutics and treatment combinations by Johnson, Mariah L., Elgamal, Ola A., Harrington, Bonnie, Mustonen, Allison, Lehman, Amy, Bennett, Chad, Dzwigalski, Kyle R., Hill, Kasey L., Phelps, Mitch A., Truxall, Jean, Goodwin, Thomas, Shih, Alan H., Levine, Ross L., Hertlein, Erin, Byrd, John C.

“…Introduction Acute myeloid leukemia (AML) is a disease characterized by the proliferation of undifferentiated myeloid blasts, promoting bone marrow failure,…”
Get full text